Due to sensitivity and invasiveness issues, the use of implanted NMR microprobes remains a poorly explored field of research, with no emerging or significant biomedical applications. In this study, we report the realization, characterization and applicaiton of an innovative design for implantable microprobe allowing a drastic minimization of the probe invasiveness. The results obtained in vitro and in vivo demonstrate the potential of this microprobe architecture for MRS and MRI investigation of organs and tissues in submicroliter volumes.
The architecture of the NMR microprobe is sketched in Figure 1. Copper wires (with diameter of 50 or 100 μm) were wounded (2 turns) around a thin cylindrical rigid support (250-μm diameter). Both sides of the wire were then twisted together and inserted inside a biocompatible polyamide tubing (12-mm length with inner and outer diameter of 350 and 380 μm). The rigid support was then removed and a biocompatible glue was used to seal the polyamide tube and to fix the surface coil at the extremity of the polyamide tubing. The two sides of the wire were then connected to variable tuning and matching capacitors mounted on an adjacent circuit board. The connecting wires between the upper exit of the polyamide tubing and the tuning capacitor were 12 mm in length. The microcoils were tuned to either 200 or 300 MHz, corresponding to proton Larmor frequency at 4.7 and 7 T. The photograph in Figure 2 shows one example of manufactured microprobe using 50-μm diameter wire and a 320-μm diameter surface coil. In vitro and in vivo experiments were performed using Bruker Biospec MRI scanners (4.7 and 7 T) running under Paravision. NMR spectra were acquired using single-pulse sequence with typical excitation pulse length of 7 μs and 2 W excitation pulse power. Shimming was performed using an automatic first‐ and second‐order Bruker shimming procedure. 3D MRI acquisitions were performed using ZTE sequence with TE=8 μs and FOV= 10 mm3. Male Wistar rats were used for in vivo experiment. The rats were anesthetized and positioned in a stereotaxic instrument for the implantation of a cannula (450-μm inner diameter) for latter insertion of the NMR microprobe in the animal brain. The in vivo MR experiments took place at least 24 hours after the surgery and positioning of the cannula.
1. Grayson A.C.R. et al. A BioMEMS review: MEMS technology for physiologically integrated devices. Proceedings of the IEEE. 92,1, 6-21 (2004).
2. P. Hickey, M. Stacy. Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's Disease. Frontiers in Neuroscience. 10, 173 (2016).
Fig4. In vivo microcoil acquisitions at 7 Tesla in rat brain. The FWHM of the lactate peak is in the order of 54 Hz and its SNR equal to 21 with 5 minutes total acquisition time.
Fig5. The left side image displays the implantation path and the position of the microprobe in the rat brain. The right side images shows the volume rendering of the 3D ZTE acquisition acquired using the surface microcoil (superimposed to ZTE acquisition in the most right image). The sensitive volume of detection of the microprobe is in the order of 300 nanoliters.